Bo Zhong

Exposure–Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing

A. Gajjar, G. Robinson, C. Stewart, 2019, Clinical Cancer Research.

CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model.

M. Roussel, C. Stewart, D. Farmer, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.

M. Roussel, C. Stewart, Bo Zhong, 2021, Journal of pharmaceutical and biomedical analysis.

CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice.

C. Stewart, Victoria A. Haberman, L. Janke, 2019, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Development and validation of a sensitive LC MS/MS method for the measurement of the checkpoint kinase 1 inhibitor prexasertib and its application in a cerebral microdialysis study

M. Roussel, C. Stewart, A. Maharaj, 2018, Journal of Pharmaceutical and Biomedical Analysis.

LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors.

C. Stewart, R. Salloum, O. Campagne, 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.